Yuki Hiroshima Katsushi Tajima Yousuke Shiono Ikuko Suzuki Kei Kouno Masakazu Yamamoto Yuichi Kato Takeo Kato
10.1007/s00277-012-1410-9
Ann Hematol
2012 Sep;91(9):1499-500.
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/22281990/
Antibodies, Monoclonal, Murine-Derived / pharmacokinetics Ascites / metabolism Lymphoma, Follicular / drug therapy
Antibodies, Monoclonal, Murine-Derived / pharmacokinetics Ascites / metabolism Lymphoma, Follicular / drug therapy Case Reports Letter Adult Antibodies, Monoclonal, Murine-Derived / administration & dosage Antibodies, Monoclonal, Murine-Derived / blood Antibodies, Monoclonal, Murine-Derived / therapeutic use Antineoplastic Agents / blood Antineoplastic Agents / pharmacokinetics Antineoplastic Agents / therapeutic use Antineoplastic Combined Chemotherapy Protocols / administration & dosage Antineoplastic Combined Chemotherapy Protocols / therapeutic use Ascites / drug therapy Ascites / etiology Cyclophosphamide / administration & dosage Doxorubicin / administration & dosage Humans Lymphoma, Follicular / complications Male Prednisone / administration & dosage Recurrence Remission Induction Rituximab Vincristine / administration & dosage Antibodies, Monoclonal, Murine-Derived Antineoplastic Agents Rituximab Vincristine Doxorubicin Cyclophosphamide Prednisone CHOP protocol
PMC3411293
22281990
Rituximab pharmacokinetics in ascites and serum in the treatment of follicular lymphoma with massive ascites
2012